Here's a summary of the provided transcript in a self-contained bullet list format, including timestamps, important details, and key takeaways:
Infectious Disease Puscast #74: A Review of Recent ID Literature
0:00 Introduction: Drs. Daniel Griffin and Sarah Dong introduce the podcast, covering infectious disease literature from January 30th to February 12th, 2025.
1:07 MMWR Scarcity Discussed: The hosts note the unusual lack of publications on the Morbidity and Mortality Weekly Report (MMWR).
2:08 Viral Section - Polio Vaccine: Discussion of an article on the "Global impact of mass vaccination campaigns on circulating type 2 vaccine-derived poliovirus outbreaks." The study compared a novel oral polio vaccine (nOPV2) to the traditional monovalent oral polio vaccine (mOPV2) and found no significant difference in preventing outbreaks, except maybe in the DRC. Reinforces the push for inactivated polio vaccine (IPV).
4:32 Viral Section - COVID-19 and Influenza Co-infection: A meta-analysis ("Co-infection of SARS‐CoV‐2 and influenza A/B among patients with COVID-19") showed a 14% prevalence of influenza co-infection in COVID-19 patients. Emphasizes the importance of testing for both viruses.
5:52 Viral Section - Oseltamivir Mortality Benefit: A study ("Oseltamivir reduces 30-Day mortality in older adults with Influenza") demonstrated that oseltamivir (Tamiflu) reduces 30-day mortality in older adults with influenza A, even when initiated after 48 hours.
7:24 Bacterial Section - Corticosteroids in Pneumonia: A meta-analysis ("Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia") suggests that corticosteroids may benefit patients with community-acquired pneumonia, particularly those with high C-reactive protein (CRP) levels. Steroid use showed a potential increased risk of hyperglycemia and hospital readmission.
12:08 Bacterial Section - Spontaneous Bacterial Peritonitis (SBP) Prophylaxis: The authors of "Rethinking antibiotic prophylaxis for spontaneous bacterial peritonitis in patients with cirrhosis" discuss a call to re-evaluate long-term antibiotic prophylaxis for SBP in cirrhosis patients, citing weak evidence for benefit and potential harms (e.g., antimicrobial resistance, C. difficile).
14:37 Bacterial Section - Antibiotic Duration for Skin Infections: "Determining the optimal antibiotic duration for skin and soft tissue infections" highlights that shorter antibiotic courses (often less than 10 days) are generally sufficient for skin and soft tissue infections, even in cases of obesity or diabetic foot infections with osteomyelitis (6 weeks max, even for the non-surgical approach). Longer durations may increase treatment failure.
17:17 Bacterial Section - Kingella kingae Outbreaks: "The stealth and potentially fatal nature of Kingella kingae outbreaks in daycare facilities" reviews K. kingae, a cause of bone and joint infections, particularly in young children (6 months to 2 years). Discusses outbreaks in daycare settings and the challenges of diagnosis and management (prophylaxis for contacts?).
19:53 Bacterial Section - AmpC Beta-Lactamase Producing Bacteria: A meta-analysis ("Piperacillin/tazobactam vs. cefepime or carbapenems for the treatment of bloodstream infections due to bacteria producing chromosomal AmpC beta-lactamase") found no significant difference in mortality between piperacillin/tazobactam and cefepime/carbapenems for bloodstream infections caused by AmpC-producing bacteria. Cefepime showed a lower mortality rate compared to carbapenems. Highlights the need for RCTs.
22:30 Bacterial Section - BCG Vaccine and Systemic Dissemination: "Is systemic dissemination of BCG following neonatal vaccination required for protection against Mycobacterium tuberculosis?" explores the hypothesis that systemic dissemination of BCG after neonatal vaccination is crucial for protection against TB. Discusses how testing this hypothesis could inform future TB vaccine development.
25:37 Bacterial Section - Fluoroquinolones and Aortic Aneurysm: "Risk of aortic aneurysm or dissection following use of fluoroquinolones: a retrospective multinational network cohort study" A large retrospective study found no increased risk of aortic aneurysm or dissection with fluoroquinolone use compared to Bactrim or cephalosporins in the treatment of UTI.
26:47 Fungal Section - The Last of Us Season 2: A reminder that season 2 of "The Last of Us" is coming in April.
26:52 Fungal Section - Cryptococcosis Vaccine: A study ("Developing mRNA lipid nanoparticle vaccine effective for cryptococcosisin a murine model") demonstrated the potential of an mRNA-lipid nanoparticle vaccine to protect against cryptococcal infection in a mouse model.
28:14 Fungal Section- Fungal Spider Pathogen: The hosts discuss: "The araneopathogenic genus Gibellula (Cordycipitaceae: Hypocreales) in the British Isles, including a new zombie species on orb-weaving cave spiders (Metainae: Tetragnathidae)" and the report of a new fungal species (Gibellula attenboroughii) that infects cave-dwelling spiders in the British Isles, causing behavioral changes similar to "zombie ants."
31:34 Fungal Section: Cooccidiodes Serology in the Immunocompromised Sensitivity of Coccidioides serologic tests were reviewed and results showed that Coccidioides serology is less reliable in patients with hematologic malignancies, highlighting the need for antigen testing and/or empiric treatment in high-risk, symptomatic patients.
33:18 Parasitic Section - New WHO Guidelines for HAT: New WHO guidelines ("New WHO guidelines for treating rhodesiense human African trypanosomiasis: expanded indications for fexinidazole and pentamidine") recommend fexinidazole as first-line therapy for rhodesiense human African trypanosomiasis (East African sleeping sickness) in individuals 6 years and older, regardless of disease stage.
35:04 Parasitic Section - Onchocerciasis Elimination in Niger: WHO verified Niger as the first country in the African region to eliminate onchocerciasis (river blindness).
35:44 Miscellaneous Section - Telemedicine in ID: "Telemedicine offers solutions for the rural disparities in infectious disease (ID) care delivery" highlights the growing shortage of ID physicians, particularly in rural areas, and advocates for telemedicine as a solution to improve access to ID care.
38:11 Show Close: Information for providing feedback and supporting MicrobeTV is provided.